New heart valve device shows promise in early trial

NCT ID NCT05712161

Ongoing Disease control Sponsor: Anteris Technologies Ltd. Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026

Summary

This early study tests a new device called DurAVR™ THV for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow and stiff. The study involves 15 participants aged 65 and older who need a valve replacement. The goal is to see if the device is safe and can be placed successfully through a tube in the leg artery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States
Columbia University Medical Center/NYPH

New York, New York, 10032, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
Tucson Medical Center

Tucson, Arizona, 85712, United States
University of Michigan

Ann Arbor, Michigan, 48109, United States

Conditions

The condition(s) this trial relates to.

aortic valve calcification aortic valve stenosis Aortic Valve, Calcification of

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC STENOSIS AORTIC VALVE CALCIFICATION SEVERE AORTIC VALVE STENOSIS SYMPTOMATIC AORTIC STENOSIS